Treatment of diffuse large B-cell lymphoma with rituximab, intensive induction and high-dose consolidation: The final analysis of the Czech Lymphoma Study Group (CLSG) R-MegaCHOP-ESHAP-BEAM (R-MEB) trial

Abstract

Treatment of high-risk aggressive lymphomas with intensive chemoimmunotherapy